NovoCure News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.11.20	Novocure Prices $500 Million 0% Convertible Senior Notes Private Placement (Businesswire)
02.11.20	Novocure Announces Proposed Private Placement of $500 Million of Convertible Senior Notes (Businesswire)
29.10.20	Novocure Reports Third Quarter 2020 Financial Results and Provides Company Update (Businesswire)
29.10.20	Novocure Announces Strategic Alliance with NYU Grossman School of Medicine for Preclinical and Clinical Research (Businesswire)
27.10.20	Ausblick: NovoCure präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
13.10.20	Erste Schätzungen: NovoCure zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
02.10.20	Novocure to Report Third Quarter 2020 Financial Results (Businesswire)
30.09.20	So schätzen die Analysten die NovoCure-Aktie im September 2020 ein (finanzen.net)
29.09.20	Novocure to Host Virtual Research & Development Day (Businesswire)
25.09.20	Novocure Honors Mesothelioma Day with Activities to Raise Awareness of Mesothelioma and Support the Community (Businesswire)
04.09.20	Novocure to Participate in the 2020 Wells Fargo Virtual Healthcare Conference (Businesswire)
13.08.20	Novocure Announces Expansion of Its Executive Leadership Team (Businesswire)
30.07.20	Novocure Reports Second Quarter 2020 Financial Results and Provides Company Update (Businesswire)
28.07.20	Novocure Announces Recipients of 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program (Businesswire)
22.07.20	First Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays (Businesswire)
15.07.20	Novocure Announces Clinical Trial Collaboration with MSD to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Non-Small Cell Lung Cancer (Businesswire)
15.07.20	Erste Schätzungen: NovoCure legt Quartalsergebnis vor (finanzen.net)
08.07.20	Novocure Announces Over 100 Physicians in the U.S. Now Certified to Prescribe Optune Lua™ (Businesswire)
07.07.20	Novocure Enrolls Last Patient in HEPANOVA Trial Testing Tumor Treating Fields in Combination with Sorafenib in Advanced Liver Cancer (Businesswire)
01.07.20	Novocure to Report Second Quarter 2020 Financial Results (Businesswire)
02.06.20	Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data (Businesswire)
31.05.20	So stuften die Analysten die NovoCure-Aktie im vergangenen Monat ein (finanzen.net)
13.05.20	China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma (Businesswire)
30.04.20	So stuften die Analysten die NovoCure-Aktie im vergangenen Monat ein (finanzen.net)
30.04.20	Novocure Reports First Quarter 2020 Financial Results and Provides Company Update (Businesswire)
29.04.20	Ausblick: NovoCure veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
15.04.20	Erste Schätzungen: NovoCure mit Zahlen zum abgelaufenen Quartal (finanzen.net)
03.04.20	Novocure Provides Business Update Related to COVID-19 (Businesswire)
27.03.20	Gemeinsamer Bundesausschuss beschliesst Aufnahme von TTFields in die Richtlinie Methoden Vertragsärztlicher Versorgung (MVV-RL) (Businesswire)
20.03.20	German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany (Businesswire)
19.03.20	Novocure Announces Optune Lua™ as the Brand Name for the NovoTTF-100L™ System (Businesswire)
12.03.20	Preclinical Data Show Tumor Treating Fields Induces Immunogenic Cell Death Resulting in Enhanced Antitumor Efficacy When Combined with Anti-PD-1 Therapy (Businesswire)
27.02.20	Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update (Businesswire)
26.02.20	Ausblick: NovoCure veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
21.01.20	Novocure Announces National Reimbursement in Israel for Optune® in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma (Businesswire)
13.01.20	Novocure Announces Fourth Quarter and Full Year 2019 Preliminary Net Revenues and Provides Company Update (Businesswire)
09.01.20	Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer (Businesswire)
26.12.19	Novocure to Participate in the 38th Annual J.P. Morgan Healthcare Conference (Businesswire)
02.12.19	Novocure and the AACR Announce 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program (Businesswire)
26.11.19	Novocure to Participate in the Evercore ISI 2019 HealthCONx Conference (Businesswire)
20.11.19	Novocure Announces 43 Presentations on Tumor Treating Fields at 24th Annual Meeting of the Society for Neuro-Oncology (Businesswire)
31.10.19	Novocure Reports Third Quarter 2019 Financial Results and Provides Company Update (Businesswire)
16.10.19	Results from STELLAR Trial of Tumor Treating Fields with Chemotherapy in Malignant Pleural Mesothelioma Published in The Lancet Oncology (Businesswire)
01.10.19	Novocure to Report Third Quarter 2019 Financial Results (Businesswire)
09.09.19	Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting (Businesswire)
16.08.19	Can NovoCure Hit $100? (RTTNews)
12.08.19	China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China (Businesswire)
06.08.19	Novocure to Participate in Three Upcoming Investor Conferences (Businesswire)
25.07.19	Novocure Reports Second Quarter 2019 Financial Results and Provides Company Update (Businesswire)
23.07.19	Ausblick: NovoCure stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	74.04	2.41 %	K V
ABB	52.12	1.68 %	K V
Geberit	552.80	1.32 %	K V
Alcon	78.04	1.19 %	K V
CieFinRichemont	129.05	1.10 %	K V
Swiss Life Hldg	686.00	-0.64 %	K V
Zurich Insur Gr	555.20	-1.00 %	K V
Holcim	90.66	-1.31 %	K V
Kuehne+Nagel Int	210.60	-1.31 %	K V
Novartis	90.10	-3.14 %	K V

Nachrichten zu NovoCure Limited

Aktien Top/Flop

Meistgelesene Nachrichten